Definition

A critical quality attribute (CQA) is a physical, chemical, biological, or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure desired product quality.

CQAs may include

assay, impurities, potency, sterility, endotoxin, dissolution, particulate matter, aggregation, or other attributes that could affect patient safety or product efficacy if they fall outside acceptable limits.

Why Are Critical Quality Attributes Important?

Critical quality attributes provide the scientific basis for process development, process validation, analytical testing, control strategy development, and facility and equipment design.

• Defines which quality characteristics matter most to product performance and patient safety.
• Connects product knowledge to process design and control strategy.
• Supports validation acceptance criteria and batch release decisions.
• Guides monitoring during CPV and annual product review.

What Does a Critical Quality Attribute Strategy Include?

A CQA strategy connects product requirements to product and process understanding, analytical controls, risk assessment, and lifecycle monitoring.

Quality Target Product Profile (QTPP)

Defines the intended use, dosage form, route of administration, strength, stability, and clinical performance.

Product Understanding

Scientific understanding of the product’s molecular characteristics, formulation, mechanism of action, stability, and manufacturing process.

Risk Assessment

Risk assessments identify which quality attributes are critical and which process variables influence them.

Analytical Characterization

Analytical methods used to measure assay, impurities, potency, sterility, endotoxin, dissolution, particulate matter, aggregation, or other attributes.

Specifications and acceptance criteria

CQAs may be tied to release specifications, in-process limits, validated methods, or lifecycle monitoring expectations.

Process Understanding

Determines which parameters influence CQAs, including parameter interactions and process capabilities.

Control Strategy

Controls may include raw-material specifications, equipment specifications, automation controls, in-process monitoring and testing, and release testing.

Lifecycle monitoring

CQA trends should be reviewed over time to confirm the process remains controlled and capable of producing quality product.

Common Critical Quality Attribute Challenges

• CQAs are overidentified without a clearly documented rationale.
• Product knowledge is insufficient to justify CQA designation.
• The relationship between CQAs and CPPs is not defined clearly.
• Analytical-method variability prevents robust measurement of CQAs.

Best Practices for Critical Quality Attributes

• Define CQAs using product knowledge, clinical relevance, regulatory commitments, and quality risk management.
• Maintain traceability from the QTPP to CQAs, CPPs, control strategies, validation activities, and continued process verification.
• Continuously monitor CQA trends through CPV.
• Reassess CQAs when product, process, method, equipment, or regulatory expectations change.

How Mangan Biopharm Supports Critical Quality Attributes

Mangan Biopharm supports CQA definition and lifecycle management through process validation, control strategy development, data integrity support, validation data management, and CPV trend review.